Home > Insider Trading > Filing (0001628280-20-013721)

Filing Details

Accession Number:: 0001628280-20-013721
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-17 21:10:35
Reporting Period:: 2020-09-15

Accepted Time:: 2020-09-17 21:10:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576280	Guardant Health Inc.	GH	Services-Medical Laboratories (8071)	454139254

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1752968	Helmy Eltoukhy	505 Penobscot Drive Redwood City CA 94063	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-09-15	22,926	$4.18	3,317,456	No	4	M	Direct
Common Stock	Disposition	2020-09-15	37,474	$102.21	3,279,982	No	4	S	Direct
Common Stock	Disposition	2020-09-15	29,785	$103.30	3,250,197	No	4	S	Direct
Common Stock	Disposition	2020-09-15	42,106	$104.04	3,208,091	No	4	S	Direct
Common Stock	Disposition	2020-09-15	683	$104.79	3,207,408	No	4	S	Direct
Common Stock	Acquisiton	2020-09-16	45,523	$4.18	3,252,931	No	4	M	Direct
Common Stock	Disposition	2020-09-16	43,351	$103.05	3,209,580	No	4	S	Direct
Common Stock	Disposition	2020-09-16	152,011	$104.07	3,057,569	No	4	S	Direct
Common Stock	Disposition	2020-09-16	23,147	$104.61	3,034,422	No	4	S	Direct
Common Stock	Acquisiton	2020-09-17	42,921	$4.18	3,077,343	No	4	M	Direct
Common Stock	Disposition	2020-09-17	8,570	$99.16	3,068,773	No	4	S	Direct
Common Stock	Disposition	2020-09-17	76,084	$100.02	2,992,689	No	4	S	Direct
Common Stock	Disposition	2020-09-17	111,591	$100.94	2,881,098	No	4	S	Direct
Common Stock	Disposition	2020-09-17	9,728	$102.10	2,871,370	No	4	S	Direct
Common Stock	Disposition	2020-09-17	48	$102.82	2,871,322	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	STOCK OPTION (RIGHT TO BUY)	Disposition	2020-09-15	22,926	$0.00	22,926	$4.18
Common Stock	STOCK OPTION (RIGHT TO BUY)	Disposition	2020-09-16	45,523	$0.00	45,523	$4.18
Common Stock	STOCK OPTION (RIGHT TO BUY)	Disposition	2020-09-17	42,921	$0.00	42,921	$4.18

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
861,532	2022-07-13	No	4	M	Direct
816,009	2022-07-13	No	4	M	Direct
773,088	2022-07-13	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	664,020	Indirect	Shares held by Eltoukhy Investments, L.P.

Footnotes

These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $101.70 to $102.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $102.70 to $103.695, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $103.70 to $104.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $104.73 to $104.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $102.475 to $103.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $103.47 to $104.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $104.47 to $105.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $98.71 to $99.705, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $99.71 to $100.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $100.71 to $101.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $101.71 to $102.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Includes shares previously reported as indirectly held by the Helmy A. Eltoukhy Revocable Trust.
The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.